Article
Irvine, CA-In anticipation of the initial public offering (IPO) of its common stock, IntraLase Corp. has filed a registration statement with the Securities and Exchange Commission.
New miniature telescope for AMD shows promise, raises postoperative concerns
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Treating systemic inflammation may protect against diabetes
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Study finds faricimab effective for nAMD patients unresponsive to other anti-VEGF treatments
Nuance Audio hearing aid glasses receive FDA approval as a medical device